Engineering bioactive mineralized tumor cells for tumor immunotherapy

Together, our study highlights the immense potential of engineering bioactive mineralized tumor cells to facilitate whole-cell tumor vaccine-based immunotherapy.

Authors

Institutions

Publication Details

Journal
Frontiers in Bioengineering and Biotechnology
Published
2025-04-01
DOI
https://doi.org/10.3389/fbioe.2025.1582490
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Engineering bioactive mineralized tumor cells for tumor immunotherapy

Ren Mo, Dan Shao, Ziyang Shen, Yan He
Frontiers in Bioengineering and Biotechnology
Immunotherapy and Immune Responses
article

Engineering bioactive mineralized tumor cells for tumor immunotherapy

Ren Mo, Dan Shao, Ziyang Shen, Yan He
article en

Abstract

Together, our study highlights the immense potential of engineering bioactive mineralized tumor cells to facilitate whole-cell tumor vaccine-based immunotherapy.

Frontiers in Bioengineering and BiotechnologyVol. 13
South China University of Technology (CN)
Good health and well-being
Openalex Percentile: Top 92%
Immunotherapy and Immune Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Engineering bioactive mineralized tumor cells for tumor immunotherapy — Ren Mo, Dan Shao, et al. · Frontiers in Bioengineering and Biotechnology (2025) | TGRS Research Map | TGRS